Most catastrophic birth injuries we review turn on a fast-moving emergency — a placental abruption, a cord prolapse, a heart-rate tracing that fell apart in twenty minutes. Kernicterus is different, and that difference is the whole point. It rarely happens in a single terrible moment. It develops over hours and days, usually after the baby has been born healthy, sometimes after the family has already gone home. That slow timeline is exactly why kernicterus is one of the few catastrophic birth injuries that modern medicine considers almost entirely preventable — and why, when it happens anyway, the records tend to tell a clear story about what was and wasn't done.
When Herb Borroto, M.D., J.D., reviews a jaundice case, he is not looking for a dramatic event. He is looking for a number that was never drawn, a rising trend that was noted but not acted on, or a discharge that happened without anyone reading the one chart that predicts risk. Here is a plain-English read on how untreated jaundice injures the brain, what the current standard of care requires, and what these cases look like from the inside.
What Is Kernicterus, and How Does Jaundice Cause It?
Kernicterus is permanent brain damage caused by extremely high levels of bilirubin, the yellow pigment that produces the visible skin and eye color of jaundice. Almost every newborn has some jaundice in the first days of life because a baby's liver is still learning to clear bilirubin. In most infants the level rises, peaks, and falls harmlessly. The danger begins when bilirubin climbs far above the safe range and crosses into the brain, where it is toxic to specific structures — the basal ganglia and the brainstem nuclei that control movement, hearing, and eye movement.
Doctors describe this injury in two stages. The acute phase is acute bilirubin encephalopathy — the reversible-to-partly-reversible window when a severely jaundiced baby becomes lethargic, feeds poorly, and develops abnormal muscle tone. The chronic, permanent result is kernicterus (now often called kernicterus spectrum disorder). The key fact for parents: once the brain cells are injured, the damage does not heal. There is no treatment that reverses kernicterus. Everything in the medical playbook is aimed at stopping bilirubin before it gets there.
Why Is Kernicterus Considered Almost Entirely Preventable?
Kernicterus sits in a category that frustrates clinicians and lawyers alike, because the tools to prevent it are cheap, fast, and universally available. A bilirubin level can be estimated painlessly with a light meter on the skin (transcutaneous bilirubin) and confirmed with a small blood draw (total serum bilirubin). The main treatment, phototherapy, is simply placing the baby under special blue lights that break bilirubin down into a form the body can excrete. It is one of the safest, most established treatments in all of newborn medicine. In the rare cases where bilirubin is already at a critical level, an exchange transfusion can remove it directly.
None of this is experimental or resource-intensive. That is why the U.S. Centers for Disease Control and Prevention and the American Academy of Pediatrics have both described kernicterus as a "never event" — the kind of outcome that, with proper monitoring, essentially should not occur in a developed healthcare system. When it does occur, the question is almost never "was there a cure we missed?" It is "was the baby watched the way the standard of care requires?"
The central insight of a jaundice case. Because prevention is so straightforward, these cases rarely turn on a difficult medical judgment call. They turn on whether routine, low-tech steps — measure, chart, treat, follow up — were actually performed and documented. That makes the medical record unusually decisive.
What Does the 2022 AAP Guideline Actually Require?
In 2022 the American Academy of Pediatrics published a major revision of its clinical practice guideline, Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. It is the current national standard, and it sharpened several expectations that matter directly to liability:
- Universal predischarge screening. Every newborn should have a bilirubin level measured at least once before going home — not just the babies who look yellow. Visual assessment alone is unreliable, especially in infants with darker skin.
- Hour-specific, risk-adjusted thresholds. There is no single "danger number." The guideline uses nomograms that set the treatment threshold based on the baby's exact age in hours, gestational age, and whether neurotoxicity risk factors are present. A level that is fine for a healthy 40-week baby can require phototherapy in a 35-week baby.
- An "escalation of care" threshold. The 2022 guideline added a distinct, higher line that signals a medical emergency — the point at which the team should be preparing for possible exchange transfusion and urgent intervention, not just continuing routine phototherapy.
- Risk-based follow-up timing. The predischarge bilirubin value is supposed to drive when the baby is seen again — sometimes within 24 hours — and that risk information must be communicated to whoever handles follow-up.
- Race removed as a "protective" factor. The revision removed older language treating Black race as protective against severe jaundice, after data showed hazardous hyperbilirubinemia in Black infants. Assuming lower risk based on skin tone is no longer defensible.
The foundation underneath these thresholds is the hour-specific bilirubin nomogram popularized by Dr. Vinod Bhutani, which plots a baby's level against age in hours to predict the risk of the level climbing into a dangerous zone. When a case turns on "should they have acted sooner," this is the chart the experts are reading.
Which Babies Are at Higher Risk?
The 2022 guideline identifies specific neurotoxicity risk factors that lower the threshold for treatment — meaning these babies should be treated at a lower bilirubin level than an otherwise healthy newborn. A care team that misses these factors is reading the wrong line on the chart. They include:
- Gestational age below 38 weeks (the risk rises the earlier the birth).
- A low blood albumin level (below 3.0 g/dL), because albumin binds bilirubin and keeps it out of the brain.
- Isoimmune hemolytic disease — most commonly ABO or Rh incompatibility between mother and baby, which speeds bilirubin production.
- G6PD deficiency, an inherited condition that causes red blood cells to break down faster.
- Sepsis or significant clinical instability.
Two of these — prematurity even by a week or two, and hemolytic disease — come up again and again in the cases we see, because they accelerate the rise and are precisely the situations where earlier, more aggressive monitoring is required.
What Does Acute Bilirubin Encephalopathy Look Like?
Parents are often the first to notice that something is wrong, and the early signs are easy to dismiss as a sleepy or fussy newborn. Clinicians describe acute bilirubin encephalopathy as progressing through phases:
- Early: the baby is unusually sleepy and hard to wake, has poor suck and feeding, and has decreased muscle tone (floppiness).
- Intermediate: irritability, a high-pitched cry, increasing muscle tone with arching of the neck and back (retrocollis and opisthotonus), and sometimes fever.
- Advanced: pronounced arching, an inability to feed, pauses in breathing (apnea), seizures, and unresponsiveness.
The intermediate and advanced signs are red flags that demand emergency treatment. A baby who is markedly jaundiced, feeding poorly, and arching is not a baby to send home with reassurance — recognizing that picture and acting on it is squarely within the standard of care.
What Are the Permanent Effects of Kernicterus?
Because bilirubin targets specific brain structures, chronic kernicterus tends to produce a recognizable, well-documented combination of injuries often called the classic tetrad:
- Movement disorder — a choreoathetoid or dystonic form of cerebral palsy, with involuntary writhing movements and abnormal tone.
- Hearing loss — sensorineural hearing loss or auditory neuropathy spectrum disorder, sometimes the most prominent finding.
- Eye-movement problems — impaired upward gaze in particular.
- Dental enamel dysplasia — abnormal enamel on the baby teeth.
Notably, children with kernicterus often have relatively preserved intellect, which makes the movement and communication disabilities especially significant — and makes lifelong support, therapy, and equipment central to their future. Our companion post on what a life care plan is and why it matters explains how those long-term needs are documented.
What Do the Malpractice Cases Look Like?
Across jaundice cases, a handful of failure patterns recur. Each maps to a step the 2022 AAP guideline treats as routine:
- No predischarge bilirubin measured. The baby is sent home without the single screening test that predicts risk, so no one knows where the level actually was.
- A high or rapidly rising level noted but not acted on. The number is in the chart, sometimes flagged, but phototherapy is not started or the baby is not kept for observation.
- Reading the wrong threshold. The team treats a premature or hemolytic baby as if it were a low-risk full-term infant, applying a threshold that is too high for that child.
- Early discharge without risk-based follow-up. A newborn goes home at 24–48 hours — when bilirubin is still climbing — with no timely recheck scheduled and no clear instructions to the family.
- Failure to recognize acute encephalopathy. A lethargic, poorly feeding, arching, deeply jaundiced baby is reassured rather than urgently tested and treated.
- Communication breakdown at handoff. The birth hospital's bilirubin data never reaches the pediatrician responsible for follow-up, so the risk is invisible to the next clinician.
What Records Decide These Cases?
Jaundice cases are won and lost in a specific and unusually concrete set of documents. When Herb Borroto, M.D., J.D., reads a birth chart alongside Alex Alvarez, Board Certified Civil Trial Lawyer, these are the records that carry the weight:
- Every transcutaneous and total serum bilirubin value, with the exact date and time — because plotting them against the baby's age in hours is what reveals whether the trend was dangerous.
- The maternal and infant blood typing and any Coombs (direct antiglobulin) test, which establish hemolytic risk.
- The gestational age and delivery summary, which set the correct risk threshold.
- Nursing notes and feeding records documenting alertness, tone, and how the baby was eating.
- The discharge summary and the discharge instructions given to the family — including whether and when follow-up was scheduled.
- The pediatric follow-up (or emergency readmission) records showing what happened after the baby went home.
Because the timeline of a bilirubin level is objective and time-stamped, these cases often come down to a chart that can be read the same way by any qualified reviewer. A jaundice case is frequently a fetal-monitoring case's opposite: instead of interpreting an ambiguous strip, the reviewer is confirming whether simple, well-defined steps were taken on schedule.
If Your Child Was Injured by Untreated Jaundice
If your baby developed kernicterus, was hospitalized for severe jaundice, or later received a diagnosis of a movement disorder or hearing loss that traces back to the newborn period, the medical record usually tells a clear story to someone trained to read it. A free case review looks at whether the bilirubin was measured and monitored the way the standard of care requires, and whether the filing deadlines are still open — which, for injuries to a child, often run far longer than parents expect.
- Understand how bilirubin injury overlaps with brain injury: HIE & birth asphyxia and cerebral palsy.
- Learn how long-term needs are documented: What is a life care plan.
- Understand the deadlines: Birth injury statute of limitations.
Every birth is different, every chart is different, and every state's rules are different. Past results do not guarantee similar outcomes, and each case is evaluated on its own facts. If liability can be established, families of a child harmed by preventable jaundice may have a claim.
Sources
- American Academy of Pediatrics — Kemper AR, et al. "Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation." Pediatrics, 2022. publications.aap.org
- American Academy of Pediatrics — Hyperbilirubinemia clinical resources and 2022 guideline FAQ. aap.org
- U.S. Centers for Disease Control and Prevention — Facts about jaundice and kernicterus. cdc.gov
- Bhutani VK, et al. — Hour-specific bilirubin nomogram for predicting risk of significant hyperbilirubinemia. Pediatrics. ncbi.nlm.nih.gov
- American Academy of Family Physicians — "Neonatal Hyperbilirubinemia: Evaluation and Treatment." American Family Physician, 2023. aafp.org